News

Diabetes Australia applauds the decision by Health Minister Greg Hunt and the Federal Government to list Ryzodeg on the Pharmaceutical Benefits Scheme (PBS) from 30 July 2018.

Ryzodeg is a combination of ultra-long acting and rapid-acting insulin delivered in a once-daily injection that will eliminate the need for multiple daily injections and make diabetes management easier and less intrusive for some people.

Insulin injections are one of the most intrusive parts of living with diabetes. All people living with type 1 diabetes who are not using insulin pumps and many people with type 2 diabetes have to inject themselves with insulin multiple times during the day.

Every day scientists are learning more about the links between type 2 diabetes and dementia. Both conditions can have a major impact on a person’s quality of life as they age.

This why Diabetes Australia is supporting research into how a process known as oxidative stress contributes to the development of both conditions.

Dr Camilla Hoyos from the University of Sydney is leading a project which is using MRI scanning to assess levels of oxidative stress within the brain.

Australians with all types of diabetes, who often see a range of health professionals to manage their condition, could see the biggest health benefits from having a My Health Record.

My Health Record is an online health record, that enables the safe storage, access and sharing of important health information. It will improve communication between GPs, endocrinologists (diabetes specialists), diabetes educators, optometrists, podiatrists and other health professionals that provide care to people with diabetes.

Heart disease will shorten the lives of many people living with type 2 diabetes by almost a decade, however new research supported by Diabetes Australia could pave the way to earlier identification and earlier treatment.

Dr Kwok Leung Ong, from the University of NSW, is leading the study to identify biomarkers, detectable characteristics, that could help identify people with type 2 diabetes who are at a higher risk of heart disease.

A new report authored by Professor Stephen Colagiuri has found less than 40 per cent of people with diabetes complete the annual cycle of care – a series of health checks with different health professionals designed to keep people healthy.

“Overall the data indicates that many people with diagnosed diabetes in Australia are not receiving expected standards of diabetes care,” Professor Colaguiri said.

Leading diabetes and eye health groups today applauded the Australian Government funding announcement for a new national diabetes eye screening program to reduce vision loss and blindness in people with diabetes.

The Australian-first initiative program is a major step in the fight against diabetes related blindness and will enable early detection and treatment to protect the sight of over 1.2 million Australians living with diabetes.

The fear of diabetes-related complications, like blindness and limb amputation, is something people with all types of diabetes sometimes experience but for people with type 1 diabetes diagnosed as children they have a lifetime to live with those fears.

However a new study, funded by the Diabetes Australia Research Trust, hopes to discover the best treatment strategies for reducing a person’s long-term risk.

Diabetes Australia has warned that failure to implement a comprehensive national type 2 diabetes early detection program could be costing the Australian health system more than $700 million each year.

Diabetes Australia is calling for emergency departments and GP clinics across Australia to conduct more routine detection in a bid to diagnose up to 500,000 Australians who may currently have silent, undiagnosed type 2 diabetes.

People can have type 2 diabetes for up to seven years before it is diagnosed and in that time many people will begin to develop debilitating complications including heart attacks and strokes, eye damage and blindness, foot ulcers and limb amputation, and kidney damage. In many cases, complications can be prevented with early detection and optimal treatment.

A national survey by Diabetes Australia has found two thirds of people with type 2 diabetes don’t know heart disease is the number one cause of death for people with type 2 diabetes.

Only 12 per cent of people thought they were at risk of heart disease and 6 per cent thought they were personally at risk of having a heart attack.

For the third consecutive year, in support of National Diabetes Week, Energizer® will donate $1 for every specially marked pack purchased to Diabetes Australia. By buying a specially marked battery pack, buyers will be supporting the life-changing work of Diabetes Australia.